Status:
RECRUITING
Database for Interstitial Lung Disease
Lead Sponsor:
Medical University of Graz
Collaborating Sponsors:
Boehringer Ingelheim
Conditions:
Lung Diseases, Interstitial
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to establish a clinical database for patients bearing at risk for ILD (Interstitial Lung Disease) and to set up a prospective ILD Screening program for these patients.
Eligibility Criteria
Inclusion
- Age: ≥ 18 years
- patients with a known systemic disease bearing a risk for ILD
- signed informed consent (for prospective part)
Exclusion
- Age \< 18 years
- comorbidities severely limiting life-expectancy (e.g. severe cardiovascular conditions, malignant disease)
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2026
Estimated Enrollment :
412 Patients enrolled
Trial Details
Trial ID
NCT04707781
Start Date
May 1 2021
End Date
January 31 2026
Last Update
October 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Graz, Department of Internal Medicine, Division of Pulmonology
Graz, Austria, 8036